PBLS — Parabilis Medicines, Inc.
$24.44-9.21%
Last close: · regular session
Last 17 sessions
PBLS closed at $24.44 (-9.21%) on Oct 23, 2026. Float: 101.2M shares. Latest SEC filing: 8-K on Sep 15, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for PBLS in the TickerWise workspace.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 145
- Website: http://www.parabilismed.com
Latest SEC filings for PBLS
Latest PBLS news
- Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors Read article
- Regeneron-backed Parabilis rises ahead of trial data for lead asset Read article
- Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis Read article
- Parabilis Medicines (NASDAQ:PBLS) Shares Gap Up – Here’s What Happened Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.